<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02548923</url>
  </required_header>
  <id_info>
    <org_study_id>UTMCKTRAUMA1</org_study_id>
    <nct_id>NCT02548923</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients</brief_title>
  <official_title>Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tennessee Graduate School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Tennessee Graduate School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the efficacy of dexmedetomidine versus propofol for
      prolonged sedation in trauma and surgical patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: Open-label, single-center prospective study. Setting: Trauma/Surgical Intensive Care
      Unit (TSICU) at a Level I academic trauma center.

      Patients: Patients 18 years of age or older requiring mechanical ventilation and admitted to
      the TSICU Interventions: Patients were randomly assigned based on unit bed location to
      receive dexmedetomidine or propofol for sedation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Mechanical Ventilation</measure>
    <time_frame>ICU stay</time_frame>
    <description>An average of 10 days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Hospital length of stay</time_frame>
    <description>An average of 21 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of time in target sedation</measure>
    <time_frame>ICU length of stay</time_frame>
    <description>AN average of 10 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of delirium</measure>
    <time_frame>ICU length of stay</time_frame>
    <description>An average of 10 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hypotension</measure>
    <time_frame>ICU length of stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bradycardia</measure>
    <time_frame>ICU length of stay</time_frame>
    <description>AN Average of 10 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>hospital length of stay</time_frame>
    <description>An average of 21 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who received dexmedetomidine for sedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients who received propofol for sedation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>comparison to propofol</description>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <other_name>Propofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients were included in the study if they were 18 years of age or older,

          -  mechanically ventilated,

          -  placed on the institutional sedation protocol,

          -  expected to require sedation lasting 24 hours after randomization, and

          -  admitted to the TSICU and followed by the Trauma/Surgical Service.

        Exclusion Criteria:

        Patients were excluded for any of the following:

          -  72 hours or greater since sedation protocol initiation,

          -  treatment per the institutional traumatic brain injury (TBI) protocol,

          -  concomitant continuous infusion of a neuromuscular blocking agent,

          -  heart rate less than 50 beats per minute,

          -  mean arterial pressure less than 55 mmHg despite fluid resuscitation and vasopressors,
             and

          -  use of other alpha-2 agonists within 24 hours of randomization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Tennessee Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37922</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>September 11, 2015</last_update_submitted>
  <last_update_submitted_qc>September 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Tennessee Graduate School of Medicine</investigator_affiliation>
    <investigator_full_name>Brian Daley</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

